Table 1.
Representative miRNAs regulating pathophysiology of AD
miRNA | Sample type | Cell | Regulation | Target | Function | Mechanism | Ref. |
---|---|---|---|---|---|---|---|
miR‐21 | NA | VSMC | Increased | SMAD7 | Promote phenotypic transition | TGF‐β signalling pathway | 63 |
miR‐134‐5p | Thoracic aorta | VSMC | Decreased | STAT5B/ITGB1 | Inhibit phenotypic transition/apoptosis | ITGB1/CRE signalling pathway | 19 |
miR‐145 | Ascending aorta | VSMC | Decreased | CTGF | Inhibit apoptosis | TGF‐β/SMAD3 signalling pathway | 20, 67 |
miR‐320 | Peripheral blood | Monocytes, macrophage | Decreased | MMP2/9 | Inhibit degradation/remodelling of the ECM | Post‐transcriptional control | 69 |
miR‐320d/582 | Thoracic aorta | VSMC | Decreased |
TRIAP1/NET1, COLIA1/SPP1 |
Inhibit apoptosis | Apoptotic pathway | 21 |
miR‐144‐3p | Dissection specimens | VSMC | Increased | TE | Reduce elastin | Protein translation | 73 |
miR‐146b | Peripheral blood | VSMC, EC, MPh | Increased | NF‐κB1/TRAF6/MMP6/ACTA2 | Promote inflammation/apoptosis/ECM degradation | TLR/TGF‐β signalling pathway | 76 |
miR‐146a‐5p | TAAD plasma sample and tissue | VSMC | Increased | SMAD4 | Promote the proliferation and migration of VSMC | TGF‐β signalling pathway | 82 |
miR‐30a | Ascending aorta | VSMC | Increased | LOX | Inhibit cross‐link collagen and elastin | Inhibit the protein abundance of LOX | 83 |
miR‐143/145 | Ascending aorta | VSMC | Decreased | TGF‐β1/P38‐MAPK | Inhibit phenotypic transition | TGF‐β1 signalling pathway | 12, 52 |
miR‐4787‐5p/4306 | Peripheral blood | VSMC | Increased | PKD1/TGF‐β1 | Damage cell‐cell adhesion/inflammation | TGF‐β1 signalling pathway | 90 |
miR‐26b | Ascending aorta | VSMC | Increased | HMGA2 | Promote apoptosis EMT | TGF‐β signalling pathway | 94 |
Abbreviations: EC, endothelial cell; ECM, extracellular matrix; EMT, endothelial‐mesenchymal transition; MPh, macrophages; TAAD, thoracic aortic aneurysm and dissection; TE, tropoelastin; VSMC, vascular smooth muscle cell.